A Naturally Occurring Human Minidysferlin Protein Repairs Sarcolemmal Lesions in a Mouse Model of Dysferlinopathy
- 22 September 2010
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 2 (50) , 50ra69
Abstract
Dysferlinopathies are autosomal recessive, progressive muscle dystrophies caused by mutations in DYSF, leading to a loss or a severe reduction of dysferlin, a key protein in sarcolemmal repair. Currently, no etiological treatment is available for patients affected with dysferlinopathy. As for other muscular dystrophies, gene therapy approaches based on recombinant adeno-associated virus (rAAV) vectors are promising options. However, because dysferlin messenger RNA is far above the natural packaging size of rAAV, full-length dysferlin gene transfer would be problematic. In a patient presenting with a late-onset moderate dysferlinopathy, we identified a large homozygous deletion, leading to the production of a natural “minidysferlin” protein. Using rAAV-mediated gene transfer into muscle, we demonstrated targeting of the minidysferlin to the muscle membrane and efficient repair of sarcolemmal lesions in a mouse model of dysferlinopathy. Thus, as previously demonstrated in the case of dystrophin, a deletion mutant of the dysferlin gene is also functional, suggesting that dysferlin’s structure is modular. This minidysferlin protein could be used as part of a therapeutic strategy for patients affected with dysferlinopathies.Keywords
This publication has 39 references indexed in Scilit:
- Efficient recovery of dysferlin deficiency by dual adeno-associated vector-mediated gene transferHuman Molecular Genetics, 2010
- Efficient bypass of mutations in dysferlin deficient patient cells by antisense-induced exon skippingHuman Mutation, 2009
- Genetic Manipulation of Dysferlin Expression in Skeletal MuscleThe American Journal of Pathology, 2009
- Intravenous Administration of Self-complementary AAV9 Enables Transgene Delivery to Adult Motor NeuronsMolecular Therapy, 2009
- How to go about diagnosing and managing the limb-girdle muscular dystrophiesNeurology India, 2008
- Safety and Efficacy of AAV-Mediated Calpain 3 Gene Transfer in a Mouse Model of Limb-Girdle Muscular Dystrophy Type 2AMolecular Therapy, 2006
- Packaging Capacity of Adeno-Associated Virus Serotypes: Impact of Larger Genomes on Infectivity and Postentry StepsJournal of Virology, 2005
- Rescue of Dystrophic Muscle Through U7 snRNA-Mediated Exon SkippingScience, 2004
- Defective membrane repair in dysferlin-deficient muscular dystrophyNature, 2003
- Plasma Membrane Repair Is Mediated by Ca2+-Regulated Exocytosis of LysosomesCell, 2001